Literature DB >> 28169460

Alterations of the hematologic cells in synthetic cannabinoid users.

Derya Guzel1, Ahmet Bulent Yazici2, Esra Yazici3, Atila Erol3.   

Abstract

BACKGROUND: Functions, morphology, distributions, and index of the circulating cells are the most useful parameters that indicate various inflammatory and toxic conditions. The aim of this study was to investigate the clinical significance of these parameters in patients diagnosed with (synthetic) cannabis use disorder.
METHODS: This study included a total of 40 patients in the study group (SG) with synthetic cannabis use; and 40 healthy individuals as the control group (CG). Participants, who had hematological disorders and other chronic diseases, were excluded from the study. All hematological parameters of SG were compared with CG. Neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) values were calculated and compared between groups.
RESULTS: There were statistically significant differences between the groups in terms of WBC, MCH, RDW, MCV, MPV, and NEU, LYM%, MONO% parameters (P<.05). MPW and LYM% were significantly lower in SG compared to CG. WBC, MCH, RDW, MCV, MPV, MONO, and NEU parameters were significantly higher in SG compared to CG (P<.05). UIBC and TIBC levels were significantly higher in SG compared to CG (P<.001). Although there was statistically significant difference between groups in terms of NLR, there was no significant difference for PLR values.
CONCLUSION: Our data suggested that chronic use of cannabinoids can lead to deterioration of hematopoietic cells. Chronic use of cannabinoids was consistent with subthreshold/subclinical megaloblastic anemia with iron deficiency. Inflammatory cells, especially neutrophil and monocyte counts were higher in SG compared to CG. Thus, recovery of subclinical hematological parameters should be considered in cannabis use disorder patients.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  hematologic cells; inflammation; marijuana; synthetic cannabinoids

Mesh:

Substances:

Year:  2017        PMID: 28169460      PMCID: PMC6817267          DOI: 10.1002/jcla.22131

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  51 in total

Review 1.  The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome.

Authors:  Ioannis Kyrou; George Valsamakis; Constantine Tsigos
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

Review 2.  Coronary plaque disruption.

Authors:  E Falk; P K Shah; V Fuster
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

Review 3.  General pharmacological actions of some synthetic tetrahydrocannabinol derivatives.

Authors:  H F Hardman; E F Domino; M H Seevers
Journal:  Pharmacol Rev       Date:  1971-12       Impact factor: 25.468

Review 4.  Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55.

Authors:  Nariman A B Balenga; Christopher M Henstridge; Julia Kargl; Maria Waldhoer
Journal:  Adv Pharmacol       Date:  2011

5.  Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome.

Authors:  Umesh U Tamhane; Sanjay Aneja; Daniel Montgomery; Eva-Kline Rogers; Kim A Eagle; Hitinder S Gurm
Journal:  Am J Cardiol       Date:  2008-06-26       Impact factor: 2.778

6.  Mechanism of platelet activation induced by endocannabinoids in blood and plasma.

Authors:  S Annette Brantl; Anna L Khandoga; Wolfgang Siess
Journal:  Platelets       Date:  2013-06-21       Impact factor: 3.862

7.  Beyond THC: The New Generation of Cannabinoid Designer Drugs.

Authors:  Liana Fattore; Walter Fratta
Journal:  Front Behav Neurosci       Date:  2011-09-21       Impact factor: 3.558

8.  Inflammatory cytokines in general and central obesity and modulating effects of physical activity.

Authors:  Frank M Schmidt; Julia Weschenfelder; Christian Sander; Juliane Minkwitz; Julia Thormann; Tobias Chittka; Roland Mergl; Kenneth C Kirkby; Mathias Faßhauer; Michael Stumvoll; Lesca M Holdt; Daniel Teupser; Ulrich Hegerl; Hubertus Himmerich
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

9.  Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.

Authors:  Thomas Gary; Martin Pichler; Klara Belaj; Franz Hafner; Armin Gerger; Harald Froehlich; Philipp Eller; Peter Rief; Gerald Hackl; Ernst Pilger; Marianne Brodmann
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

Review 10.  Application of Innovative Hemocytometric Parameters and Algorithms for Improvement of Microcytic Anemia Discrimination.

Authors:  Margreet Schoorl; Marianne Schoorl; Johannes van Pelt; Piet C M Bartels
Journal:  Hematol Rep       Date:  2015-06-23
View more
  1 in total

1.  Acute carotid thrombosis and ischemic stroke following overdose of the synthetic cannabinoid K2 in a previously healthy young adult male.

Authors:  Raihan Faroqui; Peter Mena; Allen R Wolfe; Joseph Bibawy; George A Visvikis; Michael T Mantello
Journal:  Radiol Case Rep       Date:  2018-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.